Earnings

InVentiv 1Q Profit Slips On Communications Revenue

 

SOMERSET, N.J. (AP) — InVentiv Health Inc., which provides services for the pharmaceutical and life sciences industries, said Friday its profit slipped 2 percent in the first quarter due to falling demand for its communications business.

InVentiv also targeted a second quarter profit that was just below analyst estimates, and narrowed its annual profit forecast.

The company earned $7.9 million, or 24 cents a share, in the three months ended March 31 from $8 million, or 24 cents a share, a year ago.

Revenue also slipped 2 percent to $257.7 million from $262.3 million, with communications revenue sliding 20 percent as customers delayed their purchases in the early part of the quarter.

Thomson Reuters says analysts expected a smaller profit of 19 cents per share and $268.8 million in revenue.

InVentiv's communications revenue fell to $70.9 million, and clinical revenue decreased 2 percent to $51.2 million. Commercial revenue rose 12 percent to $103.2 million, and patient outcomes revenue grew 8 percent to $32.4 million.

The company said communications revenue was slow at the beginning of the quarter, but improved as the period went on. The division helps clients learn about the market for their product, and develop and execute marketing plans.

>To order reprints of this article, click here: Reprints

Copyright 2009 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

TheStreet Premium Services

Jim Cramer
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
OptionsProfits
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
Dow Jones S&P 500 NASDAQ 10-Year Note
12,393.45 1,310.33 2,827.34 15.81
Oil *
101.78
DOWN
26.41
DOWN
2.99
DOWN
10.02
DOWN
0.44
10 Yr
1.58%
SPDR Gold
151.62
-0.21%
-0.23%
-0.35%
-2.71%
Data delayed 20 minutes

Top Stories and Tools

Articles From

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy.
Podcasts

Connect with TheStreet